Pharmacokinetics, safety, and tolerability of multiple-dose CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in healthy Japanese and non-Japanese adults

Authors
Category Primary study
ConferenceThe International Liver Congress
Year 2021
This article has no abstract
Epistemonikos ID: 42a35dedec2701dad7b332a74b6957a1305b1ed2
First added on: Sep 12, 2025